Skip to main content
. 2021 Feb 5;5:PO.20.00287. doi: 10.1200/PO.20.00287

FIG 1.

FIG 1.

Disease courses for patients 1 (top) and 2 (bottom) aligned by date of diagnosis. The date when metastatic disease was first radiographically evident is indicated with an M in blue. CA19-9 test results are not shown because—for both patients—they were reproducibly approximately 90% lower than the 37 U/mL threshold for normal, even when the primary tumor was present. This result suggests a false negative result because of a Lewisa-b- antigen phenotype, as is the case for 5%-10% of Caucasian patients with PDAC.65